ArticleiMeta2025

RRM2-targeted nanocarrier enhances radiofrequency ablation efficacy in hepatocellular carcinoma through ferroptosis amplification and immune remodeling.

Weiliang Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.